Researcher Obligations to Participants in Novel COVID-19 Vaccine Research

"Researcher Obligations to Participants in Novel COVID-19 Vaccine Research." The American Journal of Bioethics, 23(10), pp. 119–120

This article is referred to by:

Social Value, Beneficial Information, and Obligations to Participants in a Trial of Novel COVID-19 Vaccines

Clinicians Doing Research Should Use Their Clinical Expertise to Help Study Participants

Ancillary Care Obligations of Clinical Trial Investigators in the COVID-19 Pandemic

Ethical Vaccine Recommendations in the Context of Tenuous Data: Honesty is the Best Policy

DISCLOSURE STATEMENT

Liza-Marie Johnson and Benjamin S. Wilfond are the co-editors and Devan M. Duenas is the managing editor.

Additional information

Funding

Research reported in this publication was supported by the Institute of Translational Health Sciences, funded by the National Center for Advancing Translational Sciences of the National Institutes of Health under award number UL1TR002319. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.